z-logo
open-access-imgOpen Access
Linagliptin—Role in the Reversal of A β ‐Mediated Impairment of Insulin Signaling and Reduced Neurotoxicity in AD Pathogenesis: Some Considerations
Author(s) -
Srinivas Nuggehally R.
Publication year - 2015
Publication title -
cns neuroscience and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 69
eISSN - 1755-5949
pISSN - 1755-5930
DOI - 10.1111/cns.12475
Subject(s) - linagliptin , saxagliptin , incretin , vildagliptin , dipeptidyl peptidase 4 , pharmacology , insulin , medicine , sitagliptin , insulin receptor , diabetes mellitus , metformin , type 2 diabetes , endocrinology , insulin resistance

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here